Minerva Neurosciences (NERV) Insider Trading & Ownership $1.74 +0.10 (+5.79%) Closing price 07/11/2025 03:51 PM EasternExtended Trading$1.73 -0.01 (-0.29%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Minerva Neurosciences (NASDAQ:NERV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.60%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)$192.50K Get NERV Insider Trade Alerts Want to know when executives and insiders are buying or selling Minerva Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NERV Insider Buying and Selling by Quarter Minerva Neurosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/1/2023Frederick W AhlholmCFOSell3,580$4.48$16,038.40 5/1/2023Geoff RacePresidentSell22,082$3.85$85,015.70 5/1/2023Remy LuthringerCEOSell23,753$3.85$91,449.05 (Data available from 1/1/2013 forward) NERV Insider Trading Activity - Frequently Asked Questions Who is on Minerva Neurosciences' Insider Roster? The list of insiders at Minerva Neurosciences includes Frederick W Ahlholm, Geoff Race, and Remy Luthringer. Learn more on insiders at NERV. What percentage of Minerva Neurosciences stock is owned by insiders? 8.60% of Minerva Neurosciences stock is owned by insiders. Learn more on NERV's insider holdings. Minerva Neurosciences Key ExecutivesDr. Remy Luthringer Ph.D. (Age 63)Executive Chairman & CEO Compensation: $1.27MMr. Geoffrey Robin Race F.C.M.A. (Age 63)M.B.A., President Compensation: $913.3kMr. Frederick W. Ahlholm CPA (Age 58)Senior VP, CFO & Secretary Compensation: $726.02kMr. Joseph Reilly (Age 49)Senior VP & COO Compensation: $461kMr. William B. Boni (Age 72)Vice President of Investor Relations & Corporate Communications Prof. Michael Davidson M.D. (Age 74)Chief Medical Officer Compensation: $657.47k More Insider Trading Tools from MarketBeat Related Companies Eyenovia Insider Selling Medicus Pharma Insider Selling Nabriva Therapeutics Insider Selling Applied Therapeutics Insider Selling Pluri Insider Selling Prelude Therapeutics Insider Selling Mural Oncology Insider Selling Scilex Insider Selling Exicure Insider Selling Acrivon Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Do They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold? This page (NASDAQ:NERV) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
